Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis.

Mattthew James Sinclair ParkerAdelle S JeeDylan HansenSusanna ProudmanPeter YoussefTony J KennaWendy StevensMandana NikpourJoanne SahharTamera J Corte

Published in: Rheumatology (Oxford, England) (2024)

Multiple biomarkers, especially VCAM-1, E-Selectin, SP-D and CXCL4, provide prognostic utility beyond that of established risk factors for patients with SSc.

Keyphrases

systemic sclerosis
interstitial lung disease
rheumatoid arthritis
idiopathic pulmonary fibrosis
cardiovascular events
risk factors
cardiovascular disease
coronary artery disease
cell adhesion